QUICK CONTACT FORM
Attorney/Client relationship
Largest Dangerous Drug Settlements
A middle-aged woman sustained serious heart valve injury (i.e.
primary pulmonary hypertension) from taking a prescribed diet drug
Redux, which contains Fen/Phen. Our firm maintained joint responsibility with an experienced drug injury
firm who settled the case.
$2.5 Million Settlement
A wife and mother of two children died of a cerebral hemorrhage
after taking an over the counter diet drug diet drug containing
Ephedra. The deceased’s husband contacted our firm for help.
Our firm maintained joint responsibility with an experienced product liability attorney who settled
the case.
$900,000 Settlement
We were co-counsel in a case involving a dietary supplement with
PPA. The client suffered a stroke and had a brain bleed that required
two surgeries. Our firm maintained joint responsibility with an experienced product liability attorney
who settled the case.
$ 750,000 Settlement
A teenager committed suicide after taking an anti-depressant drug
for several weeks. The young boy’s life was cut short just
one week before his birthday. Our firm maintained joint responsibility with an experienced product liability
attorney who settled the case.
$1.25 Million Settlement
Our client was the mother of a one year old child who was born with a complex cardiovascular condition. The child was diagnosed with arterial septal defect, ventricular septal defect and congestive heart failure, all conditions caused by the mother's use of Paxil during the first trimester of her pregnancy. Our firm maintained joint responsibility with an experienced drug injury firm who settled the case.
$800,000 Settlement
When Baycol was removed from the market in 2001, we were contacted by many Rhode Islanders who were injured by this medication. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, who was successful in negotiating a multi-million dollar settlement for several clients.
$2 Million in total Settlements
Due to taking the drug zyprexa, a number of our clients developed type 2 diabetes as a side effect. Our firm maintained joint responsibility with a pharmaceutical litigation law firm, who was successful in negotiating a multi-million dollar settlement for our clients.
$3.8 Million in total
Settlements
A Connecticut man was diagnosed with Type II diabetes after using the medication, Zyprexa. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, and the case was settled out of court.
$500,000 Settlement
Pradaxa Lawyer - d'Oliveira & Associates
The blood-thinning drug PRADAXA has been linked to fatal internal bleeding and heart attacks. The FDA approved Pradaxa in October 2010 and it is manufactured by Boehringer Ingelheim Pharmaceuticals. Pradaxa is used to treat atrial fibrillation, an irregular heartbeat that can increase a patient’s risk of stroke. A study published in the Archives of Internal Medicine in 2012 found that Pradaxa was “significantly associated with a higher risk” of heart attacks and acute coronary syndrome compared to the alternative wafarin.
The FDA received reports of over 500 cases of hemorrhaging in the first quarter of 2011 alone. The median age of patients with serious bleeding issues is 80 years old, with at least a quarter of the patients over the age of 84. In the fall of 2011, there were reports that as many as 260 deaths worldwide have been linked to Pradaxa. Many of these deaths may have been a result of internal bleeding.
SYMPTOMS OF INTERNAL BLEEDING INCLUDE:
- Unusual bleeding or bruising
- Coughing up or vomiting blood
- Headaches and dizziness
- Weakness or swelling of arms and legs
- Pink or brown colored urine
- Red or black tarry stools
The manufacturers of Pradaxa marketed the drug to be a more convenient alternative to the standard blood thinning medication wafarin, which has been used for decades. However, bleeding caused by the drug wafarin can be cancelled with doses of vitamin K, whereas bleeding from Pradaxa has no antidote and can have fatal consequences. In November of 2011, the European Medicines Agency recommended that physicians assess patients’ renal function before prescribing Pradaxa, and that they exercise caution if prescribing it to elderly patients or patients with renal impairment.
PLEASE SPEAK WITH YOUR DOCTOR BEFORE DISCONTINUING USE OF PRADAXA OR ANY OTHER PRESCRIPTION MEDICATION.
Contact the Law Offices of d'Oliveira & Associates, P.C.
If you believe that you or one of your loved ones have been injured by PRADAXA, you may want to speak with a personal injury attorney regarding a potential claim. An injury lawyer familiar with new developments in the investigation of PRADAXA may be able to help you make important personal and legal decisions. d’Oliveira & Associates, P.C. is working with some of the leading lawyers in the country who are handling these cases.Please contact the law offices of d'Oliveira & Associates, P.C. at 1-800-992-6878 or fill out a contact form for a free legal consultation.